Who
Charles David Pauza
Chief Science Officer Virology
Company insider
Files Form 4 as: Chief Science Officer Virology, Traws Pharma.
In numbers
- Trades disclosed
- 10
- Buys
- 0
- Sells
- 0
- Bought
- $0
- Sold
- $0
- Companies
- 1
- Companies where not an officer
- 0
- First trade
- 1 Apr 2024
- Last trade
- 9 Jul 2026
- Last filed
- 16 Jul 2026
Companies traded
Activity over time
Not enough dated trades to draw.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 9 Jul 2026filed 16 Jul 2026 | TRAW Traws Pharmaoption or derivative · Biotechnology | SEC FORM 4 Code A | —97,000 at $0.00 | filing |
| 9 Jul 2026filed 16 Jul 2026 | TRAW Traws Pharmaoption or derivative · Biotechnology | SEC FORM 4 Code A | —97,000 at $0.00 | filing |
| 8 Mar 2026filed 10 Mar 2026 | TRAW Traws Pharmaoption or derivative · Biotechnology | SEC FORM 4 Code A | —118,367 at $0.00 | filing |
| 8 Mar 2026filed 10 Mar 2026 | TRAW Traws Pharmaoption or derivative · Biotechnology | SEC FORM 4 Code A | —118,367 at $0.00 | filing |
| 12 Dec 2025filed 16 Dec 2025 | TRAW Traws Pharmaoption or derivative · Biotechnology | SEC FORM 4 Code A | —73,886 at $0.00 | filing |
| 12 Dec 2025filed 16 Dec 2025 | TRAW Traws PharmaBiotechnology | SEC FORM 4 Code A | —18,471 at $0.00 | filing |
| 12 Oct 2025filed 15 Oct 2025 | TRAW Traws Pharmaoption or derivative · Biotechnology | SEC FORM 4 Code A | —32,406 at $0.00 | filing |
| 1 Apr 2024filed 3 Apr 2024 | TRAW Traws Pharmaoption or derivative · Biotechnology | SEC FORM 4 Code A | —333,136 | filing |
| 1 Apr 2024filed 3 Apr 2024 | TRAW Traws Pharmaoption or derivative · Biotechnology | SEC FORM 4 Code A | —503,227 | filing |
| 1 Apr 2024filed 3 Apr 2024 | TRAW Traws PharmaBiotechnology | SEC FORM 4 Code A | —97,500 | filing |
News
No headline names them, or the companies they trade most, lately.
Sectors
No trade we could place in a sector.